Quthero, a Toronto, Canada-based biotech company providing a Q-peptide platform, raised $500K in funding.
The round, which was raised in addition to a co-investment of $850K for a total round size of $1.35M, saw participation from Ontario Centre of Innovation’s (OCI) Life Science Innovation Fund.
The company intends to use the funds to expand operations and development efforts.
Led by Milica Radisic, PhD, President and CEO, Quthero is discovering and developing applications for tissue regeneration. Its patented Q-peptide technology facilitates the complete regeneration of a patient’s natural tissue with minimal scarring. The company’s products are available for direct purchase on their website www.quthero.com or through participating physicians.
FinSMEs
12/03/2024